Salivary Amylase‐Responsive Buccal Tablets Wipe Out Chemotherapy‐Rooted Refractory Oral Mucositis

Salivary Amylase‐Responsive Buccal Tablets Wipe Out Chemotherapy‐Rooted Refractory Oral Mucositis

Abstract Oral mucositis (OM) is the most common and refractory complication of cancer chemotherapy and radiotherapy, severely affecting patients’ life quality, lowering treatment tolerance, and discouraging patient compliance. Current OM delivery systems mostly affect the comfort of patient use and...

Full description

Bibliographic Details
Main Authors: Yan Zhang, Taixia Wang, Xiulin Dong, Chunyan Zhu, Qiuxia Peng, Chang Liu, Yifeng Zhang, Fubo Chen, Kun Zhang
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Advanced Science
Subjects:
anti‐inflammatory
buccal tablets
refractory oral mucositis
salivary amylase response
wound healing
Online Access:https://doi.org/10.1002/advs.202308439

Internet

https://doi.org/10.1002/advs.202308439

Similar Items